Clinical Trial Update: Raspberry Ketone Intake Upregulates Circulating FGF21 and Induces Energy Expenditure in Humans [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial found that raspberry ketone intake upregulates circulating FGF21 and increases energy expenditure in humans, with obesity, diabetes, and no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes
• Nonalcoholic Fatty Liver Disease
• Obesity

Drugs mentioned

• Raspberry Ketone (raspberry ketone)

Snippet

Sponsor: Nanchang University | Conditions: Obesity, Diabetes | EARLY_Phase 1 | Status: COMPLETED